Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Identify buffer targets, automate savings, and simulate scenarios to ensure your budget remains steady when unexpected costs arise.
19,303 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Crypto executives and bank regulators left Washington with a shared sense that the work is far from over. The third W...
December data show the fed's favored inflation gauge remaining hotter than expected, underscoring persistent price pr...
A top executive at Urban Outfitters sold a sizable block of stock in a short time frame. This article breaks down wha...
Five former Binance investigators allege the exchange processed nearly $1B in Iran sanctions–related transactions aft...
Quantum hype is real, but practical gains arrive faster from AI-driven platforms and strong cash flow. This piece exp...
A viral Reddit post argues you can reach a $1.2 million nest egg by age 67 with no additional contributions, starting...
A surge in fast-food automation is reshaping kitchens and wallets. Meet your robot cooks: AI fry arms move from pilot...
As TTEC heads into 2025 earnings season, investors want a clear view of what could drive the numbers. This guide brea...
Redwire posted a strong revenue beat but a bigger-than-expected loss, triggering a mid-day rally in its stock. This a...
Institutional buyers push further into digital assets even as skeptical headlines persist. This report examines wheth...
Hidden Road's NSCC integration marks a milestone for Ripple's XRP ecosystem as RLUSD grows, boosting liquidity and in...